With doubts around the accuracy of antibody tests and slow progress on point-of-care testing, it is likely we will be waiting some time before we can confidently screen for COVID-19.
The coronavirus pandemic has been a huge challenge, but it has revolutionised pharmacy practice in some positive ways. In the second feature of a three-part series, we ask GP pharmacists which changes they want to retain.
The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.
Testing for COVID-19 antibodies has been riddled with government miscommunication and a lack of clarity, but here is what we know so far.
In the first of two podcasts exploring the MPharm degree awarding gap, four students describe what it feels like going to university to study pharmacy as an ethnic minority, and we summarise our evidence that suggests they may not be alone in their experiences.
The prime minister has said that he will put a “tiger in the tank” of Brexit talks, but what should the pharmacy profession look out for in any deal that is eventually agreed?
Drugs in space: the pharmacy orbiting the Earth Subscription
Researchers are busy developing pharmaceutical solutions for astronauts, but that extraterrestrial research could also have implications for how medicines are delivered on Earth.
Researchers around the world are working at record speed to find the best ways to treat and prevent COVID-19, from investigating the possibility of repurposing existing drugs to searching for novel therapies against the virus.
The COVID-19 pandemic has been a huge challenge, but it has revolutionised pharmacy practice in some positive ways. In the first of a three-part series, we ask hospital pharmacists which changes they want to retain.
The COVID-19 pandemic has forced radical changes to how the 2020 class of preregistration trainees will transition into their careers.
The vast majority of people with a penicillin allergy label are, in fact, not allergic, leading to significant healthcare implications. Experts say it is now time for a national “de-labelling” drive to help conserve vital antibiotics.
The under-representation of women in clinical trials is slowly being addressed, but we cannot move towards truly personalised healthcare unless we have an equal balance of the sexes in all new medicine trials.
Community pharmacy is providing a vital connection to support older and clinically vulnerable patients during lockdown in the UK.
The temporary field hospitals set up across the UK to help the NHS cope during the COVID-19 pandemic have given hospital pharmacists a unique opportunity for valuable learning and teamwork.
There has been a surge in demand for gender identity services in the UK over the past five years. Although the current role of pharmacists is limited, their potential contribution within a multidisciplinary team supporting transgender patients is beginning to emerge.
When Public Health England published new guidance on the use of personal protective equipment during the COVID-19 pandemic on 2 April 2020, pharmacy’s representative bodies thought the battle was won.
As researchers around the globe drop everything to find a treatment for COVID-19, we look at the likely frontrunners for managing this deadly disease.
Incidence of sexually transmitted infections is increasing and antimicrobial resistance is adding fuel to the fire, particularly in the case of gonorrhoea. In response, researchers are working on three major strategies to help reduce its spread and maintain susceptibility to antibiotics.
Going against type: the new class of cancer therapies targeting mutations rather than tissuesSubscription
‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
More than 18 months of hormone replacement therapy product shortages have had a drastic impact on the lives of people who rely on them, but nobody seems to know why they are happening.
The number of social prescribing staff has more than doubled in the past year, but pharmacy has yet to engage with schemes that can help patients with their wellbeing.
While medicines can be an important part of dementia treatment, there are doubts over whether they provide meaningful benefits for patients. As a result, emphasis is being placed on non-pharmacological approaches, some of which have had a transformative impact on the lives of patients with dementia.
Delays in accessing pain services in some parts of the country mean that people with chronic pain are struggling to cope.
The deadly online prescribing loopholeSubscription
Online prescribing has long operated in a regulatory grey area, with some online pharmacies evading oversight by exploiting technical loopholes in the law.
Failing the frailestSubscription
A new analysis suggests that thousands of vulnerable older people could be at risk because their medicines have not been reviewed by their GP.
A cloud of doubt over the sunshine vitaminSubscription
Negative results in trials of vitamin D supplementation have led researchers to question the best way of reaching those who are deficient.
A closer look at the progress made so far on NHS England’s new national genomic medicine service.
Are universities failing pharmacy trainees?Subscription
Graduates from some pharmacy schools achieve significantly higher final assessment pass rates than others.
A new class of sleep medicines, could provide relief for people living with insomnia, but pharmaceutical companies are struggling to bring them to the market.
Despite the rise of resistant infections, national figures show that antibiotic use continues to grow in hospitals. However, some trusts in England are stepping up their stewardship efforts and achieving significant reductions. Here, three trusts share the secrets to their success.